Concord Biotech Ltd
company logo

Concord Biotech Ltd

Concord Biotech Share Price

Pharmaceuticals
Mid Cap

-

0 (0%)


Invest in Concord Biotech Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Concord Biotech Ltd Performance

-

-

-

-


-

-

-

-

-

Concord Biotech Ltd Fundamentals

Read More

19,390.09Cr

59.12

12.19

0.01

31.35

0.47%

152.02

Concord Biotech Ltd Financials

Concord Biotech Ltd Financialsright-arrow

Concord Biotech Ltd Shareholding Pattern

Concord Biotech Ltd Delivery and Volume

About Concord Biotech Ltd

Concord Biotech Ltd was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies. Thereafter, name of the Company was changed to Concord Biotech Limited' dated February 16, 20

SUDHIR JAIRAM VAID

1984

CONCORDBIO

NameDesignation
SUDHIR JAIRAM VAIDChairman & Managing Director
ANKUR VAIDJoint Managing Director & CEO
Ravi KapoorNon Executive Director
Rajiv AgarwalNominee
BHARTI KHANNAIndependent Director
Amitabh ThakoreIndependent Director
Arvind AgarwalIndependent Director
Jayaram EaswaranIndependent Director
Mandayam Chakravarthy SriramanIndependent Director
S PrakashAssistant VP (Finance) & CS
News and Events...

Similar Stocks

What's Trending

View All
View All

Concord Biotech Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Concord Biotech Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Concord Biotech Ltd's share price is ₹1853.75 as of 2024-11-14.
Concord Biotech Ltd's P/E ratio is 59.12 times as of 2024-11-14.
Concord Biotech Ltd's most recent financial reports indicate a price-to-book ratio of 12.19, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Concord Biotech Ltd's market capitalization is ₹19390.09 Cr as on 2024-11-14.
The current financial records of Concord Biotech Ltd show a 21.63% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Concord Biotech Ltd's most recent financial filings, the company has a total asset value of ₹654.98, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Concord Biotech Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Concord Biotech Ltd's 52-week high and low as of 2024-11-14 are ₹1908.45 and ₹1836.05, respectively.